A new pharmaceutical paradigm is emerging at the intersection of mathematics, biology, and computer science. As Anna Karpenko, a research fellow at the Laboratory of Mathematical Cybernetics at the United Institute of Informatics Problems of the National Academy of Sciences of Belarus, explained in an interview with the newspaper " SOYUZ. Belarus-Russia," artificial intelligence is becoming a key tool in the creation of the drugs of the future.

Elena Basikirskaya's article "Turning on Intelligence" describes the transition from traditional chemical synthesis to computer modeling methods. The Belarusian scientific school uses machine learning algorithms to predict the properties of molecules even before they are synthesized in the laboratory. This approach not only significantly accelerates the process of bringing new drugs to market but also significantly reduces their cost.